Does ARIPIPRAZOLE LAUROXIL Cause Hospitalisation? 136 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Hospitalisation have been filed in association with ARIPIPRAZOLE LAUROXIL (ARISTADA). This represents 3.2% of all adverse event reports for ARIPIPRAZOLE LAUROXIL.
136
Reports of Hospitalisation with ARIPIPRAZOLE LAUROXIL
3.2%
of all ARIPIPRAZOLE LAUROXIL reports
0
Deaths
136
Hospitalizations
How Dangerous Is Hospitalisation From ARIPIPRAZOLE LAUROXIL?
Of the 136 reports, 136 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE LAUROXIL. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE LAUROXIL Cause?
Off label use (1,024)
Needle issue (567)
Injection site pain (426)
Drug ineffective (262)
Weight increased (207)
Product administered at inappropriate site (198)
Hallucination, auditory (172)
Therapeutic response shortened (172)
Underdose (169)
Incorrect dose administered (162)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ARIPIPRAZOLE LAUROXIL Alternatives Have Lower Hospitalisation Risk?
ARIPIPRAZOLE LAUROXIL vs ARIXTRA
ARIPIPRAZOLE LAUROXIL vs ARMODAFINIL
ARIPIPRAZOLE LAUROXIL vs AROMASIN
ARIPIPRAZOLE LAUROXIL vs ARSENIC TRIOXIDE
ARIPIPRAZOLE LAUROXIL vs ARTEMETHER\LUMEFANTRINE